Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension

European Heart Journal

Volumn 25, Issue 18, 2004, Pages 1651-1656

  Post, M C ^a   Janssens, S ^a   Van De Werf, F ^a   Budts, W ^a  

^a University Hospital   (Belgium)

Author keywords

Eisenmenger syndrome; Nitric oxide; Outcome; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DEATH; EISENMENGER COMPLEX; EVALUATION; FEMALE; FOLLOW UP; HEART DEATH; HEART LUNG TRANSPLANTATION; HUMAN; INHALATION; KAPLAN MEIER METHOD; MALE; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; VASCULAR RESISTANCE;

ADMINISTRATION, INHALATION; ADULT; AGED; ANALYSIS OF VARIANCE; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NITRIC OXIDE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 4444294201     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.07.005     Document Type: Article

References (22)

1. P. Wood The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt Br. Med. J. 46 1958 755 762
2. B.A. Reitz, J.L. Wallwork, and S.A. Hunt Heartâ€"lung transplantation: successful therapy for patients with pulmonary vascular disease N. Engl. J. Med. 306 1982 557 564
3. J. Somerville How to manage the Eisenmenger syndrome Int. J. Cardiol. 63 1998 1 8
4. W. Vongpatanasin, M.E. Brickner, and L.D. Hillis The Eisenmenger syndrome in adults Ann. Int. Med. 128 1998 745 755
5. R.J. Barst Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension Chest 89 1986 497 503
6. C. Frostell, M.D. Fratacci, and J.C. Wain Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction Circulation 83 1991 2038 2047
7. E.D. Michelakis, W. Tymchak, and M. Noga Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension Circulation 108 2003 2066 2069 Epub 2003 Oct 20
8. E.B. Rosenzweig, D. Kerstein, and R.J. Barst Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects Circulation 99 1999 1858 1865
9. W. Budts, N. Van Pelt, and H. Gillyns Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome Heart 86 2001 553 558
10. L.J. Ignarro, G.M. Buga, and K.S. Wood Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide Proc. Natl. Acad. Sci. USA 84 1987 9265 9269
11. R.T. Sperling, and M.A. Creager Nitric oxide and pulmonary hypertension Coron. Artery Dis. 10 1999 287 294
12. M. Beghetti, W. Habre, and B. Friedli Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients Br. Heart J. 73 1995 65 68
13. N. Cregg, and W. Casey Repair of ventricular septal defect in a child with severe pulmonary hypertensionâ€"response to inhaled nitric oxide Paediatr. Anaesth. 7 1997 255 258
14. O. Sitbon, F. Brenot, and A. Denjean Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A doseâ€" response study and comparison with prostacyclin Am. J. Respir. Crit. Care Med. 151 1995 384 389
15. P. Jolliet, P. Bulpa, and J.B. Thorens Nitric oxide and prostacyclin as test agents of vasoreactivity in severe precapillary pulmonary hypertension: predictive ability and consequences on haemodynamics and gas exchange Thorax 52 1997 369 372
16. O. Sitbon, M. Humbert, and J.L. Jagot Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension Eur. Respir. J. 12 1998 265 270
17. R.A. Krasuski, J.J. Warner, and A. Wang Inhaled nitric oxide selectively dilates pulmonary vasculature in adult patients with pulmonary hypertension, irrespective of etiology J. Am. Coll. Cardiol. 36 2000 2204 2211
18. H.H. Leuchte, M. Schwaiblmair, and R.A. Baumgartner Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension Chest 125 2004 580 586
19. V.V. McLaughlin, D.E. Genthner, and M.M. Panella Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series Ann. Int. Med. 130 1999 740 743
20. C.D. Vizza, S. Sciomer, and S. Morelli Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue Heart 86 2001 661 665
21. A. Saha, K.G. Balakrishnan, and P.K. Jaiswal Prognosis for patients with Eisenmenger syndrome of various aetiology Int. J. Cardiol. 45 1994 199 207
22. S.M. Arcasoy, and R.M. Kotloff Lung transplantation N. Engl. J. Med. 340 1999 1081 1091